UBS Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $42.6K | Sell |
|
|||||
|
2022
Q3 | $94K | Buy |
|
|||||
|
2022
Q2 | $41K | Sell |
|
|||||
|
2022
Q1 | $54K | Sell |
|
|||||
|
2021
Q4 | $58K | Sell |
|
|||||
|
2021
Q3 | $94K | Buy |
|
|||||
|
2021
Q2 | $108K | Sell |
|
|||||
|
2021
Q1 | $188K | Buy |
|
|||||
|
2020
Q4 | $465K | Buy |
|
|||||
|
2020
Q3 | $336K | Sell |
|
|||||
|
2020
Q2 | $513K | Sell |
|
|||||
|
2020
Q1 | $521K | Sell |
|
|||||
|
2019
Q4 | $726K | Sell |
|
|||||
|
2019
Q3 | $482K | Buy |
|
|||||
|
2019
Q2 | $814K | Buy |
|
|||||
|
2019
Q1 | $751K | Buy |
|
|||||
|
2018
Q4 | $752K | Sell |
|
|||||
|
2018
Q3 | $1.14M | Sell |
|
|||||
|
2018
Q2 | $1.3M | Sell |
|
|||||
|
2018
Q1 | $2.88M | Sell |
|
|||||
|
2017
Q4 | $7.58M | Buy |
|
|||||
|
2017
Q3 | $3.81M | Buy |
|
|||||
|
2017
Q2 | $1.37M | Sell |
|
|||||
|
2017
Q1 | $1.95M | Sell |
|
|||||
|
2016
Q4 | $1.82M | Sell |
|
|||||
|
2016
Q3 | $1.82M | Sell |
|
|||||
|
2016
Q2 | $2.46M | Sell |
|
|||||
|
2016
Q1 | $3.15M | Sell |
|
|||||
|
2015
Q4 | $4.7M | Sell |
|
|||||
|
2015
Q3 | $5.27M | Sell |
|
|||||
|
2015
Q2 | $4.21M | Sell |
|
|||||
|
2015
Q1 | $4.33M | Buy |
|
|||||
|
2014
Q4 | $3.62M | Buy |
|